Correspondence 0001104659-22-119065 from Coherus BioSciences, Inc. (CHRS) (CIK 0001512762) (CHRS)
Coherus BioSciences, Inc. (CHRS) (CIK 0001512762)
Date: Nov. 15, 2022 · CIK: 0001512762 · Accession: 0001104659-22-119065
AI Filing Summary & Sentiment
File numbers found in text: 333-268252
Letter
Coherus BioSciences, Inc.
333 Twin Dolphin Drive, Suite
Redwood City, CA 94065
November 15, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549
Re: Coherus BioSciences, Inc.
Registration Statement on Form S-3
(File No. 333-268252)
Ladies and Gentlemen:
In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Coherus BioSciences, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 initially filed on November 8, 2022 (the “Registration Statement”). The Company respectfully requests that the Registration Statement become effective as of 4:00 p.m., Eastern Time, on November 17, 2022, or as soon thereafter as practicable. Once the Registration Statement has been declared effective, please orally confirm that event with the Company’s counsel, Latham & Watkins LLP, by calling Benjamin A. Potter at (650) 470-4809.
Very truly yours,
Coherus BioSciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Coherus BioSciences, Inc.
333 Twin Dolphin Drive, Suite
600
Redwood City, CA 94065
November 15, 2022
VIA EDGAR
United States Securities and
Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549
Re:
Coherus BioSciences, Inc.
Registration Statement on Form S-3
(File No. 333-268252)
Ladies and Gentlemen:
In accordance with Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Coherus BioSciences, Inc. (the “Company”)
hereby requests acceleration of the effective date of its Registration Statement on Form S-3 initially filed on November 8, 2022 (the
“Registration Statement”). The Company respectfully requests that the Registration Statement become effective as of
4:00 p.m., Eastern Time, on November 17, 2022, or as soon thereafter as practicable. Once the Registration Statement has been declared
effective, please orally confirm that event with the Company’s counsel, Latham & Watkins LLP, by calling Benjamin A. Potter
at (650) 470-4809.
Very truly yours,
Coherus BioSciences, Inc.
By: /s/ McDavid Stilwell
Name: McDavid Stilwell
Title: Chief Financial Officer
cc:
Dennis M. Lanfear, Coherus BioSciences, Inc.
Bryan McMichael, Coherus BioSciences, Inc.
Benjamin A. Potter, Latham & Watkins LLP
Phillip S. Stoup, Latham & Watkins LLP